The progression to more advanced levels can be noted in several patients with normal ALT, and in addition, the increase in ALT not associated with hepatic steatosis is observed in obese individuals, which impairs their use in clinical practice [28, 29]. The gene discussed is GPT; the disease is Hepatic steatosis.